Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Liberum Initiates Royal Mail With Sell Rating

Thu, 07th Jan 2016 09:34

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
LIBERUM INITIATES ROYAL MAIL WITH 'SELL' - TARGET 360 PENCE
----------
UBS RAISES SAGE GROUP PRICE TARGET TO 510 (490) PENCE - 'SELL'
----------
HSBC RAISES RECKITT BENCKISER TO 'BUY' (HOLD) - PRICE TARGET 7000 (6300) PENCE
----------
EXANE BNP RAISES SMITH & NEPHEW PRICE TARGET TO 1375 (1350) P - 'OUTPERFORM'
----------
DEUTSCHE BANK RAISES HAMMERSON PRICE TARGET TO 775 (750) PENCE - 'BUY'
----------
HSBC CUTS WOLSELEY PRICE TARGET TO 4450 (4550) PENCE - 'BUY'
----------
GOLDMAN RAISES SEVERN TRENT PRICE TARGET TO 2325 (2290) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS NEXT PRICE TARGET TO 7900 (8700) PENCE - 'BUY'
----------
GOLDMAN RAISES ASTRAZENECA PRICE TARGET TO 4400 (4300) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS BURBERRY PRICE TARGET TO 1250 (1300) PENCE - 'HOLD'
----------
FTSE 250
----------
BARCLAYS CUTS IMI PRICE TARGET TO 895 (1380) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS LAIRD PRICE TARGET TO 350 (370) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS ROTORK PRICE TARGET TO 170 (287) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES HALMA PRICE TARGET TO 850 (715) PENCE - 'EQUAL WEIGHT'
----------
JEFFERIES RAISES JUST EAT PRICE TARGET TO 550 (515) PENCE - 'BUY'
----------
UBS RAISES MICRO FOCUS PRICE TARGET TO 1700 (1655) PENCE - 'BUY'
----------
UBS CUTS FIDESSA GROUP TO 'NEUTRAL' ('BUY') - TARGET 2030 PENCE
----------
UBS RAISES AVEVA GROUP PRICE TARGET TO 1800 (1750) PENCE - 'BUY'
----------
BARCLAYS CUTS SPECTRIS PRICE TARGET TO 1960 (2535) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS QINETIQ TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 270 (220) PENCE
----------
BARCLAYS CUTS RENISHAW TO 'EQUAL WEIGHT' ('OW') - TARGET 1960 (2825) PENCE
----------
CITIGROUP RAISES HOME RETAIL PRICE TARGET TO 135 PENCE - 'NEUTRAL'
----------
SOCGEN RAISES TATE & LYLE PRICE TARGET TO 700 (640) PENCE - 'BUY'
----------
GOLDMAN CUTS PENNON GROUP PRICE TARGET TO 760 (775) PENCE - 'SELL'
----------
BARCLAYS CUTS MORGAN ADVANCED MATERIALS PT TO 240 (350) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES ULTRA ELECTRONICS PT TO 1910 (1790) PENCE - 'EQUAL WEIGHT'
----------
MAIN MARKET AND AIM
----------
BARCLAYS CUTS CHEMRING GROUP PRICE TARGET TO 155 (205) PENCE - 'UNDERWEIGHT'
----------
LIBERUM RAISES SPIRENT TO 'BUY' ('HOLD') - TARGET 90 PENCE
----------
PANMURE RAISES PENNA CONSULTING PRICE TARGET TO 340 (310) PENCE - 'BUY'
----------
UBS CUTS WANDISCO PRICE TARGET TO 210 (310) PENCE - 'BUY'
----------
BARCLAYS RAISES OXFORD INSTRUMENTS PT TO 840 (750) PENCE - 'OVERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.